is saxenda a glp-1 medication (liraglutide) for the Treatment of Obesity, US New weight loss drugs, but

While GLP-1 RAs reduce food intake by dampening hyperactive reward responses to palatable cues, they appear to preserve general reward sensitivity, differentiating them from medications that blunt dopaminergic tone nonspecifically [81,92]

The literature search was independently performed by three investigators

Drugs 83 , 12931307 (2023)

Fisiopatologa y mecanismos de accin En pacientes normoglucmicos hay equilibrio entre clulas alfa (glucagn) y clulas beta (insulina) para lograr la homeostasia de glucosa ptima, pero en los pacientes con diabetes mellitus tipo 2 existe resistencia basal a la insulina que lleva a hiperinsulinemia, generando a largo plazo tolerancia a concentraciones altas de glucosa con dficit de insulina por prdida progresiva de clulas beta, as como por desdiferenciacin

503A patient-specific compounding continues under narrower legal frameworks